Chimeric Antigen Receptor T Cell Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
ACET | D | Adicet Bio, Inc. | 0.86 | |
CARM | F | Carisma Therapeutics, Inc. | 1.34 | |
CRBU | F | Caribou Biosciences, Inc. | 0.39 | |
GDTC | F | CytoMed Therapeutics Limited | -3.13 | |
GRCL | A | Gracell Biotechnologies Inc. | 0.00 | |
HGEN | F | Humanigen, Inc. | 0.00 | |
JANX | D | Janux Therapeutics, Inc. | -0.71 | |
NKTX | D | Nkarta, Inc. | -2.48 | |
NTLA | F | Intellia Therapeutics, Inc. | 1.81 | |
PSTX | D | Poseida Therapeutics, Inc. | 3.57 |
Related Industries: Biotechnology
Related Stock Lists:
Immune System
Medicine
Biopharmaceutical
Cancer
Clinical Medicine
Biotechnology
Chimeric Antigen Receptor
Lymphoma
Solid Tumors
Antigen
Cancer Immunotherapy
Cancer Treatment
Gene Therapy
Immunotherapy
Natural Killer Cell
Biology
CD19
Cell Therapy
Hematopoietic Stem Cell
Leukemia
Related ETFs - A few ETFs which own one or more of the above listed Chimeric Antigen Receptor T Cell stocks.
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
CNCR | C | Loncar Cancer Immunotherapy ETF | 5.58 | |
GNOM | D | Global X Genomics & Biotechnology ETF | 4.58 | |
ARKG | F | ARK Genomic Revolution Multi-Sector ETF | 3.94 | |
MNTL | D | Tema Neuroscience and Mental Health ETF | 3.12 | |
ARKK | C | ARK Innovation ETF | 2.75 |
Compare ETFs
Related Industries:
Biotechnology
Related Stock Lists:
Immune System
Medicine
Biopharmaceutical
Cancer
Clinical Medicine
Biotechnology
Chimeric Antigen Receptor
Lymphoma
Solid Tumors
Antigen
Cancer Immunotherapy
Cancer Treatment
Gene Therapy
Immunotherapy
Natural Killer Cell
Biology
CD19
Cell Therapy
Hematopoietic Stem Cell
Leukemia
- Chimeric Antigen Receptor T Cell
Chimeric Antigen Receptor T Cell (CAR-T) is a type of immunotherapy that uses a patient’s own T cells to fight cancer. The T cells are genetically modified to express a special receptor, called a chimeric antigen receptor (CAR), which is designed to recognize and bind to a specific protein found on the surface of cancer cells. Once the CAR-T cells bind to the cancer cells, they can kill them. CAR-T therapy has been used to treat certain types of blood cancers, such as leukemia and lymphoma, and is being studied for other types of cancer.
Recent Comments
- TraderMike on Market Recap for Friday, March 8, 2024
- Don_Marat on Market Recap for Friday, March 8, 2024
- TraderMike on Trades of the Week: Feb 12 - Feb 16, 2024
- Cos3 on Trades of the Week: Feb 12 - Feb 16, 2024
- SwingTradeBot on Market Recap for Tuesday, February 27, 2024
From the Blog
Featured Articles